Organon Reports Results for the First Quarter Ended March 31, 2022
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Merck & Co. (NYSE: MRK) | Delayed: 147.24 -2.64 (1.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $149.88 | 52 Week High | $65.46 | |||
| Open | $151.05 | 52 Week Low | $47.97 | |||
| Day High | $154.02 | P/E | 100.16 | |||
| Day Low | $144.07 | EPS | $1.47 | |||
| Volume | 19,032,504 | |||||
| (NYSE: OGN) | Delayed: 13.75 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.75 | 52 Week High | $8.00 | |||
| Open | $13.75 | 52 Week Low | $8.00 | |||
| Day High | $13.76 | P/E | N/A | |||
| Day Low | $13.74 | EPS | $0.00 | |||
| Volume | 2,553,568 | |||||
